Association between biomarkers of bone health and osteosarcopenia among Iranian older people: The Bushehr Elderly Health (BEH) program

[1]  J. Vitale,et al.  Circulating Carboxylated Osteocalcin Correlates With Skeletal Muscle Mass and Risk of Fall in Postmenopausal Osteoporotic Women , 2021, Frontiers in Endocrinology.

[2]  Pousette Hamid,et al.  Consequences of Diabetes Mellitus in Bone Health: Traditional Review , 2021, Cureus.

[3]  R. Heshmat,et al.  Prevalence of osteoporosis among the elderly population of Iran , 2021, Archives of Osteoporosis.

[4]  M. Muraca,et al.  The Role of Extracellular Vesicles (EVs) in the Epigenetic Regulation of Bone Metabolism and Osteoporosis , 2020, International journal of molecular sciences.

[5]  R. Heshmat,et al.  Comparison of EWGSOP-1and EWGSOP-2 diagnostic criteria on prevalence of and risk factors for sarcopenia among Iranian older people: the Bushehr Elderly Health (BEH) program , 2020, Journal of Diabetes & Metabolic Disorders.

[6]  Kayoung Lee.  Association of osteosarcopenic obesity and its components: osteoporosis, sarcopenia and obesity with insulin resistance , 2020, Journal of Bone and Mineral Metabolism.

[7]  R. Heshmat,et al.  Prevalence of Osteosarcopenia and Its Association with Cardiovascular Risk Factors in Iranian Older People: Bushehr Elderly Health (BEH) Program , 2019, Calcified Tissue International.

[8]  R. Heshmat,et al.  Sarcopenia disease in Iran: an overview , 2019, Journal of Diabetes & Metabolic Disorders.

[9]  G. Duque,et al.  Osteosarcopenia: A case of geroscience , 2019, Aging medicine (Milton (N.S.W)).

[10]  C. Girgis,et al.  Mice with myocyte deletion of vitamin D receptor have sarcopenia and impaired muscle function , 2019, Journal of cachexia, sarcopenia and muscle.

[11]  S. Tanishima,et al.  Association of serum bone- and muscle-derived factors with age, sex, body composition, and physical function in community-dwelling middle-aged and elderly adults: a cross-sectional study , 2019, BMC Musculoskeletal Disorders.

[12]  A. Sayer,et al.  Sarcopenia , 2019, The Lancet.

[13]  Sunghoon Kim,et al.  Clinical Manifestations and Factors Associated with Osteosarcopenic Obesity Syndrome: A Cross-Sectional Study in Koreans with Obesity , 2019, Calcified Tissue International.

[14]  René Rizzoli,et al.  Sarcopenia: revised European consensus on definition and diagnosis , 2018, Age and ageing.

[15]  R. Heshmat,et al.  Appendicular Skeletal Muscle Mass Reference Values and the Peak Muscle Mass to Identify Sarcopenia among Iranian Healthy Population , 2018, International journal of preventive medicine.

[16]  Brian C. Clark,et al.  Skeletal muscle performance and ageing , 2017, Journal of cachexia, sarcopenia and muscle.

[17]  J. Reginster,et al.  Vitamin D and osteosarcopenia: an update from epidemiological studies , 2017, Current opinion in clinical nutrition and metabolic care.

[18]  R. Heshmat,et al.  Bushehr Elderly Health (BEH) programme: study protocol and design of musculoskeletal system and cognitive function (stage II) , 2017, BMJ Open.

[19]  Chih-Hwa Chen,et al.  Bone biomarker for the clinical assessment of osteoporosis: recent developments and future perspectives , 2017, Biomarker Research.

[20]  R. Heshmat,et al.  Prevalence of sarcopenia in the world: a systematic review and meta- analysis of general population studies , 2017, Journal of Diabetes & Metabolic Disorders.

[21]  M. Greenblatt,et al.  Bone Turnover Markers in the Diagnosis and Monitoring of Metabolic Bone Disease. , 2017, Clinical chemistry.

[22]  Jie Xu,et al.  DNA methyltransferases and their roles in tumorigenesis , 2017, Biomarker Research.

[23]  K. Hill,et al.  Dysmobility syndrome: current perspectives , 2017, Clinical interventions in aging.

[24]  N. Thomas,et al.  Bone turnover markers: Emerging tool in the management of osteoporosis , 2016, Indian journal of endocrinology and metabolism.

[25]  Okhee Lee,et al.  Association of serum vitamin D with osteosarcopenic obesity: Korea National Health and Nutrition Examination Survey 2008–2010 , 2016, Journal of cachexia, sarcopenia and muscle.

[26]  G. Karsenty,et al.  Osteocalcin is necessary and sufficient to maintain muscle mass in older mice , 2016, Molecular metabolism.

[27]  A. Grey,et al.  Management recommendations for osteoporosis in clinical guidelines , 2016, Clinical endocrinology.

[28]  R. Heshmat,et al.  Bushehr Elderly Health (BEH) Programme, phase I (cardiovascular system) , 2015, BMJ Open.

[29]  C. Cooper,et al.  Osteoporosis and sarcopenia in older age. , 2015, Bone.

[30]  M. Montero‐Odasso,et al.  Phenotype of osteosarcopenia in older individuals with a history of falling. , 2015, Journal of the American Medical Directors Association.

[31]  C. Cooper,et al.  Osteoporosis in the European Union: medical management, epidemiology and economic burden , 2013, Archives of Osteoporosis.

[32]  F. Cantatore,et al.  Osteocalcin: Skeletal and extra‐skeletal effects , 2013, Journal of cellular physiology.

[33]  Prabhu K,et al.  The association of serum osteocalcin with the bone mineral density in post menopausal women. , 2013, Journal of clinical and diagnostic research : JCDR.

[34]  S. Mousa,et al.  High serum sclerostin predicts the occurrence of osteoporotic fractures in postmenopausal women: The center of excellence for osteoporosis research study , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[35]  U. Tarantino,et al.  Differential features of muscle fiber atrophy in osteoporosis and osteoarthritis , 2012, Osteoporosis International.

[36]  Avan Aihie Sayer,et al.  A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardised approach. , 2011, Age and ageing.

[37]  Bijan Iraj,et al.  Prevalence of Vitamin D Deficiency among Adult Population of Isfahan City, Iran , 2011, Journal of health, population, and nutrition.

[38]  J. Baeyens,et al.  Sarcopenia: European consensus on definition and diagnosis , 2010, Age and ageing.

[39]  N. Binkley,et al.  Beyond FRAX: it's time to consider "sarco-osteopenia". , 2009, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

[40]  P. Miller,et al.  Perspective: Assessing the Clinical Utility of Serum CTX in Postmenopausal Osteoporosis and Its Use in Predicting Risk of Osteonecrosis of the Jaw , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[41]  John A Spertus,et al.  Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement Executive Summary , 2005, Critical pathways in cardiology.

[42]  M. Seibel.  Biochemical markers of bone turnover: part I: biochemistry and variability. , 2005, The Clinical biochemist. Reviews.

[43]  Anders Isaksson,et al.  Biochemical Markers of Bone Metabolism and Prediction of Fracture in Elderly Women , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[44]  T. Jørgensen,et al.  Validation of a new self-report instrument for measuring physical activity. , 2003, Medicine and science in sports and exercise.

[45]  L. Fried,et al.  Frailty in older adults: evidence for a phenotype. , 2001, The journals of gerontology. Series A, Biological sciences and medical sciences.

[46]  P. Delmas,et al.  Markers of Bone Turnover Predict Postmenopausal Forearm Bone Loss Over 4 Years: The OFELY Study , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[47]  N. Ghannam,et al.  Book review: Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. , 1994, Annals of Saudi medicine.

[48]  Harry K. Genant,et al.  Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. , 1993, The American journal of medicine.

[49]  S. Phu,et al.  Osteosarcopenia , 2022, Sarcopenia.

[50]  M. Drey,et al.  Osteosarcopenia is more than sarcopenia and osteopenia alone , 2015, Aging Clinical and Experimental Research.

[51]  R. Krauss,et al.  Diagnosis and management of the metabolic syndrome , 2005 .

[52]  Claus Christiansen,et al.  Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. , 1994, World Health Organization technical report series.